1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > North America Autoimmune Diagnostics Market – Growth, Trends And Forecasts (2015– 2020)

North America autoimmune disease diagnostics market is estimated to reach $7.09 billion in 2020 from $5.504 billion in 2015 with a CAGR 5.24%. The term “autoimmune disease” refers to a varied group of illnesses that involve almost every human organ system. U.S being the largest market for autoimmune treatments holds 43% share in the global market, it will sustain its position and will hold 44% market share in 2016. A boost is expected for the U.S. autoimmune disease diagnostic testing market in 2014 due to the implementation of the Patient Protection and Affordable Care Act (PPACA).

Environmental, infectious, and genetic factors play an important role in initiating or exacerbating autoimmune diseases. NIH program investigates that utero exposures cause increased susceptibility to autoimmune or other diseases later in life. Increasing public awareness for autoimmune diseases, expansion in coverage allowed by Patient protection and affordable care act, increased laboratory automation are the key factors driving the North America Autoimmune disease diagnostic market. Also, increasing partnership with physicians and clinical laboratories is taking the market to higher growth levels. However, slow turnaround time for autoimmune disease diagnostic test results, high frequency of false positive results, relatively low percentage of localized autoimmune diseases are the constraints for the market growth.

NIH estimates up to 23.5 million Americans have an autoimmune disease. And in fact, of the 50 million Americans living and coping with autoimmune disease (AD), more than 75 percent of them are women. Market is estimated to grow in this region because of the increased population of women suffering from autoimmune disease.

North America autoimmune disease diagnostic market is segmented based on types i. e Localized autoimmune disease diagnostic and Systemic Autoimmune disease diagnostic segment, based on products( Drugs, Therapeutic and monitoring equipments, Diagnostic equipments), based on Service market( Consultation and Diagnosis, Therapy & Monitoring, Drug development and discovery), based on Technology( Bridge therapy, DMARD, Topical therapy, Phototherapy, Helminthes Therapy, Recombinant technology).

Major companies discussed in the report are Roche, Abbott Autoimmune, and Bayer-Schering Pharmaceuticals, Biogen Idec, Eli Lilly, GlaxoSmithKline.

What the Report Offers

1) Market Definition for North America autoimmune disease diagnostic along with identification of key drivers and restraints for the market.
2) Market analysis for the North America autoimmune disease diagnostic, with region specific assessments and competition analysis on a global and regional scale.
3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
4) Extensively researched competitive landscape section with profiles of major companies along with their share of markets.
5) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Reasons for Buying this Report

1) For gaining an exhaustive understanding of the worldwide market for North America autoimmune disease diagnostic. Would be of assistance in providing a comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade
2) An ideal opportunity for industry consultants, and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered
3) Wide-ranging information provided about the leading market players and the major strategies adopted by them

Table Of Contents

North America Autoimmune Diagnostics Market - Growth, Trends And Forecasts (2015- 2020)
Study deliverables
Market Definition
Sizing Units
Base Currency
Review and Forecast period years
General Study Assumptions
Research Methodology
Analysis Methodology
Econometric Forecast Model
Research Assumptions
Executive Summary
Key Inferences
Market Overview and Industry trends
Current Market Scenario
Technology Overview
New Developments
Industry Value chain analysis
product Life cycle analysis
Product Benchmarking
Investment Analysis
Porter's Five Forces
Bargaining Power of Suppliers
Bargaining Power of Consumers
Threat to new entrants
Threat to substitute products and services
Competitive Rivalry within the industry
Drivers, Restraints, Opportunities, and challenges Analysis
Market Drivers
Growing Public awareness of autoimmune disease
Expansion in Coverage Allowed by Patient Protection and Affordable Care Act
Improved Laboratory Automation
Partnerships with Physicians and Clinical Laboratories
Market Restraints
Slow turnaround Time for Autoimmune Disease Diagnostic Test Results
High Frequency of False Positive Results
Lacking Automation and Shortage of Skilled Technicians
Relatively low prevalence of Localized Autoimmune Diseases.

North America Autoimmune Disease Market Diagnostics - Market Segmentation

Segmentation by diagnosis
Identification of human autoantibodies
Techniques and methods used for the detection of antibodies
Enzyme immunoassay
Multiplexed immunoassays
Microarray based assays
Bead-based assay
Proteomic's technologies for the study and diagnosis of autoimmune diseases

Segmentation by types
Localized Autoimmune Disease Diagnostics Segment
Forecasts and Trends
Market Share and Competitive Analysis
Multiple Sclerosis
Inflammatory Bowel Disease
Type I Diabetes
Systemic Autoimmune Disease Diagnostics Segment
Forecasts and Trends
Market Share and Competitive Analysis
Rheumatoid Arthritis
Segmentation By Products
Therapeutic and Monitoring Equipment
Diagnostic Equipment
Segmentation, By Service Market
Consultation and Diagnosis
Therapy and Monitoring
Drug Development and Discovery
Segmentation, By Technology
DMARD (disease-modifying anti-rheumatic drugs) and biologic DMARD therapy
Bridge therapy
Topical therapy
Helminthic therapy
Haematopoietic stem-cell transplantation
Recombinant technology
North America Autoimmune Disease Market Diagnosis Segmentation, By Geography
Competitive Landscape
Merger and acquisition analysis
New Product Launches
Agreements, Collaborations and Parterships
Key Vendor Analysis
Abbott Laboratories
Bayer-Schering Pharmaceuticals
Biogen Idec
Eli Lilly
Analyst outlook for Investment opportunities
Future Outlook of the market

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Psoriatic Arthritis Pricing, Reimbursement, and Access

Psoriatic Arthritis Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • June 2016
  • by Datamonitor Healthcare

An absence of head-to-head trials, along with biosimilar launches, provide payers with leverage to demand favorable pricing for branded products in exchange for formulary access. This report addresses ...

U.S. Therapeutic Plasma Exchange Market by Indication, Procedures & Patients - Forecasts to 2021

U.S. Therapeutic Plasma Exchange Market by Indication, Procedures & Patients - Forecasts to 2021

  • $ 5 650
  • Industry report
  • July 2016
  • by MarketsandMarkets

The U.S. therapeutic plasma exchange (TPE) market by indication is estimated to reach USD 260.0 million by 2021, growing at a CAGR of 11% to 12% during the forecast period (2016 to 2021). The rising incidences ...

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

  • $ 5 650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based ...

Download Unlimited Documents from Trusted Public Sources

Infectious Disease Statistics

  • October 2016
    173 pages
  • Infectious Dise...  


  • United States  


    North America  

View report >

Mental Health Statistics and Therapy Market in the US

  • October 2016
    161 pages
  • Mental Health  



  • United States  

View report >

Neurological Disorder Statistics in the US

  • October 2016
    10 pages
  • Neurological Di...  

  • United States  

View report >

Related Market Segments :

Autoimmune Disease


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.